Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel Group Placebo-Controlled Study to Determine an Effective Dose Regimen for EPREX� (Epoetin Alfa) Sterile Solution to Reduce Transfusion Requirements in Patients Undergoing Major Elective Orthopedic Surgery

NCT00269971 is registered in ClinicalTrials.gov with Janssen-Ortho Inc., Canada as lead sponsor.

NCT NCT00269971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00269971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel Group Placebo-Controlled Study to Determine an Effective Dose Regimen for EPREX� (Epoetin Alfa) Sterile Solution to Reduce Transfusion Requirements in Patients Undergoing Major Elective Orthopedic Surgery
Lead sponsor
Janssen-Ortho Inc., Canada
Phase
Phase 3
Overall status
Withdrawn
Start date
May 31, 1996
Completion date
April 30, 1999
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, blood transfusion, orthopedic surgery